StevensH. Gilles de la Tourette and his syndrome by serendipity. Am J Psychiatry1971; 128: 489–92
3.
MurrayTJ. Dr Samuel Johnson's movement disorder. Br Med J1979; i: 1610–14
4.
BoswellJ. The Life of Johnson. London: JM Dent, 1791
5.
ItardJMG. Memoire sur quelques fonctions involontaires des appareils de la locomotion de la prehension et de la voix. Arch Gen Med1825; 8: 385–407
6.
BeardGM. Experiments with the ‘jumpers’ or ‘jumping’ Frenchmen of Maine. J Nerv Ment Dis1886; 7: 487–90
7.
de la TouretteGilles G. Étude sur une affection nerveuse caracterisée par de l'incoordination motrice accompagnée de echolalie et de copralalie. Arch Neurol. 1885; 9: 19–42, 158–200
8.
ShapiroAKShapiroESBruunRDSweetRD. Gilles de la Tourette syndrome. New York: Raven Press, 1978
9.
LeesAJRobertsonMTrimbleMRMurrayNMF. A clinical study of Gilles de la Tourette syndrome in the United Kingdom. J Neurol Neurosurg Psychiatry1984; 47: 1–8
10.
ShapiroAKShapiroESWayneHLClarkinJBruunRD. Tourette's syndrome: Summary of data on 34 patients. Psychosom Med1973; 35: 419–35
11.
CorbettJAMatthewsAMConnellPHShapiroDA. Tics and Gilles de la Tourette syndrome: A follow-up study and critical review. Br J Psychiatry1969; 115: 1129–41
12.
JaggerJPrusoffBACohenDJKiddKKCarbonariCMJohnK. The epidemiology of Tourette's syndrome: A pilot study. Schizophr Bull1982; 8: 267–78
13.
ObesoJARothwellJCMarsdenCD. The neurophysiology of Tourette syndrome. Adv Neurol1982; 35: 105–14
14.
ComingsDEComingsBG. Tourette's syndrome and attention deficit disorder with hyperactivity: Are they genetically related?J Am Acad Child Psychiatry1984; 23: 138–46
15.
NeeLECaineEDPolinskyRJ. Gilles de la Tourette syndrome: Clinical and family study in 50 cases. Ann Neurol1980; 7: 41–7
16.
NomuraYSegawaM. Gilles de la Tourette syndrome in oriental children. Brain Dev1979; 1: 103–11
17.
SweetRDSolomonGEWayneHLShapiroESShapiroAK. Neurological features of Gilles de la Tourette syndrome. J Neurol Neurosurg Psychiatry1973; 36: 1–9
18.
FeildJRCorbinKBGoldsteinNPKlassDW. Gilles de la Tourette's syndrome. Neurology (Minneap)1966; 16: 453–62
19.
VolkmarFRLeckmanJFDetlorJEEG abnormalities in Tourette's syndrome. J Am Acad Child Psychiatry1984; 23: 352–3
20.
BergenDTannerCMWilsonR. The electroencephalogram in Tourette syndrome. Ann Neurol1982; 11: 382–5
21.
KrumholzASingerHSNiedermeyerMDBurniteRHarrisK. Electrophysiological studies in Tourette's syndrome. Arch Neurol1983; 14: 638–41
22.
CaparuloBKCohenDJRothmanSLYoungJGKatzJDShaywitzSEShaywitzBA. Computed tomographic brain scanning in children with developmental neuropsychiatric disorders. J Am Acad Child Psychiatry1981; 20: 338–57
23.
ChaseTNFosterNLFedioPBrooksRMansiLKesslerRDiChiroG. Gilles de la Tourette syndrome: Studies with the Fluorine-18-labelled fluorodeoxyglucose positron emission tomographic method. Ann Neurol1984; 15 (Suppl): S175
24.
BruunRD. Gilles de la Tourette syndrome: An overview of clinical experience. J Am Acad Child Psychiatry1984; 23: 126–33
25.
EldridgeRSweetRDShapiroAArenaF. Clinical and genetic observations of 21 families with Gilles de la Tourette syndrome. Neurology (Minneap)1975; 25: 379
26.
WassmanEREldridgeRAbuzzahabSNeeL. Gilles de la Tourette syndrome clinical and genetic studies in midwestern city. Neurology (Minneap)1978; 28: 304–7
27.
GoldenG. Tics and Tourette's: A continuum of symptoms. Ann Neurol1978; 4: 145–8
28.
GuggenheimMA. Familial Tourette syndrome. Ann Neurol1979; 5: 104
29.
KiddKKPrusoffBACohenDJ. Familial pattern of Gilles de la Tourette syndrome. Arch Gen Psychiatry37:1336–9
30.
MoldofekyHTullisCLamonR. Multiple tic syndrome (Gilles de la Tourette's syndrome). J Nerv Ment Dis1974; 159: 282–91
31.
PaulsDLCohenDJHeimbuchRDetlorJKiddKK. Familial pattern and transmission of Gilles de la Tourette syndrome and multiple tics. Arch Gen Psychiatry1981; 38: 1085–90
32.
PuistSMWalsheTMRomeroJA. Carbon monoxide poisoning with features of Gilles de la Tourette's syndrome. Arch Neurol1983; 40: 443–4
33.
JenkinsRLAshbyHB. Gilles de la Tourette's syndrome in identical twins. Arch Neurol1983; 40: 249–51
34.
ShapiroAKShapiroES. Tic, Tourette or movement disorders?Diagnosis1980; 2: 76–84
35.
ComingsDEComingsBGDevorEJCloningerCR. Detection of major gene for Gilles de la Tourette syndrome. Am J Hum Genet1984; 36: 586–600
36.
DevorEJ. Complex segregation analysis of Gilles de la Tourette syndrome: Further evidence for a major locus mode of transmission. Am J Hum Genet1984; 36: 704–9
37.
RichardsonEP. Neuropathological studies of Tourette syndrome. Adv Neurol1982; 35: 83–7
38.
ShapiroAKShapiroES. Tourette syndrome: History and present status. Adv Neurol1982; 35: 17–23
39.
MahlerMSLukeJADaltroffW. Clinical and follow-up study of the tic syndrome in children. Am J Orthopsychiatry1945; 15: 631–47
FerencziS. Psycho-analytical observations on tic. Int J Psychoanal1921; 2: 1–30
42.
ObesoJARothwellJCMarsdenCD. Simple tics in Gilles de la Tourette's syndrome are not prefaced by a normal premovement EEG potential. J Neurol Neurosurg Psychiatry1981; 44: 735–8
43.
KornhuberHHDeeckeL. Hirnpotential-Anderungen bei Willkurbewegungen unter passiven Bewegungen des Menschen: Bereitschaftspotential und reafferente Potentiale. Pflugers Arch1965; 284: 1–17
44.
DeeckeLKornhuberHH. An electrical sign of the participation of the mesial supplementary motor cortex in human voluntary finger movements. Brain Res1978; 159: 473–6
45.
FahnS. A case of post-traumatic tic syndrome. Adv Neurol1982; 35: 349–50
46.
BleekerHE. Gilles de la Tourette's syndrome with clear evidence of organicity. Psychiatr Clin North Am1978; 11: 147–54
47.
SacksOW. Acquired Tourettism in later life. Adv Neurol1982; 35: 89–92
NuwerMR. Coprolalia as an organic symptom. Adv Neurol1982; 35: 363–8
50.
BennettWR. How artificial is intelligence?Am Sci1977; 65: 694–702
51.
EhringerHHornykiewiczO. Verteilung von Noradrenalin und Dopamin (3-hydroxytyramin) in Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen systems. Klin Wochenschr1960; 38: 1236–9
52.
ButlerIJKoslowSHSiefertWECaprioliRMSingerHS. Biogenic amine metabolism in Tourette syndrome. Ann Neurol1979; 6: 34–6
53.
CohenDJShaywitzBACaparuloB. Chronic multiple tics of Gilles de la Tourette's disease: CSF acid monoamine metabolites after probenecid administration. Arch Gen Psychiatry1978; 35: 245–50
54.
CohenDJYoungJGNathansonJALiebermanDBowersMBMaasJW. Central biogenic amine metabolism in children with the syndrome of chronic multiple tic of Gilles de la Tourette: Norepinephrine, serotonin, and dopamine. J Am Acad Child Psychiatry1979; 18: 320–41
55.
SingerHSTuneLEButlerIJZaczekRCoyleJT. Clinical symptomatology, CSF neurotransmitter metabolites, and serum haloperidol levels in Tourette syndrome. Adv Neurol1982; 35: 177–83
56.
CapriniGMelottiV. Un grave sindrome ticcose guarita con haloperidol. Riv Sper Freniat1961; 85: 191–6
57.
SeignotMJN. Un cas de maladie des tics de Gilles de la Tourette gueri par le R-1625. Ann Med Psychol1961; 119: 578–9
58.
AbuzzahabFSAndersonFO. Gilles de la Tourette's syndrome: International registry. Minnn Med1973; 56: 492–6
59.
ShapiroAKSuapiroES. Clinical efficacy of haloperidol, pimozide, penfluridol, and clonidine in the treatment of Tourette syndrome. Adv Neurol1982; 35: 17–23
60.
ShapiroAKShapiroESWayneHL. Treatment of Gilles de la Tourette's syndrome with haloperidol: Review of 34 cases. Arch Gen Psychiatry1973; 28: 92–6
61.
RossMSIMoldofskyH. Comparison of pimozide with haloperidol in Gilles de la Tourette's syndrome. Lancet. 1977; i: 103
62.
ShapiroAKShapiroES. Controlled study of pimozide versus placebo in Tourette's syndrome. J Am Acad Child Psychiatry1984; 23: 161–73
63.
BovisonRLAngLChangSDyskenMComatyJEDavisJM. New pharmacological approaches in the treatment of Tourette syndrome. Adv Neurol1982; 35: 377–82
64.
GoetzCGTannerCMKlawansHl. Fluphenazine and multifocal tic disorders. Arch Neurol1984; 41: 271–2
65.
StahlSMBergerPA. Cholinergic and dopaminergic mechanisms in Tourette syndrome. Adv Neurol1982; 35: 141–50
66.
BremnessABSverdJ. Methylphenidate-induced Tourette syndrome: Case report. Am J Psychiatry1979; 36: 1334–5
67.
FrasIKarlavageJ. Use of methylphenidate and imipramine in Gilles de la Tourette's disease in children. Am J Psychiatry1977; 134: 195
68.
GoldenG. Gilles de la Tourette syndrome following methylphenidate administration. Dev Med Child Neurol1974; 16: 76–8
69.
GoldenG. The effect of central nervous system stimulants on Tourette syndrome. Arch Neurol1977; 2: 69–70
70.
PollackMCohenNFriedhoffA. Gilles de la Tourette syndrome — familial occurrence and precipitation by methylphenidate. Arch Neurol1977; 34: 630–2
71.
FeinbergMCarrolBJ. Effects of dopamine agonists and antagonists in Tourette's disease. Arch Gen Psychiatry1979; 36: 979–85
72.
MeyerhoffJLSnyderSH. Catecholamines in Gilles de la Tourette's disease: A clinical study with amphetamine isomers. Adv Neurol1973; 14: 123–34
73.
SleatorEK. Deleterious effects of drugs used for hyperactivity on patients with Gilles de la Tourette syndrome. Clin Pediatr1980; 19: 453–4
74.
MitchellEMatthewsKL. Gilles de la Tourette's disease associated with pemoline. Am J Psychiatry1980; 137: 1617–19
75.
KlempelK. Gilles de la Tourette syndrome induced by L-dopa. S Afr Med J1974; 48: 1379–80
76.
MessihaFSKnoppW. A study of endogenous dopamine metabolism in Gilles de la Tourette's disease. Dis Nerv Syst1976; 37: 470–3
77.
van WoertMHRosenbaumDEnnaSJ. Overview of pharmacological approaches to therapy for Tourette syndrome. Adv Neurol1982; 35: 369–75
78.
SethyVHvan WoertMH. Regulation of striatal acetylcholine concentration by dopamine receptors. Nature1974; 251: 529–30
79.
StahlSMBergerPA. Physostigmine in Gilles de la Tourette syndrome. N Engl J Med1980; 302: 298
80.
StahlSMBergerPA. Cholinergic treatment in the Tourette syndrome. N Engl J Med1980; 302: 1310–11
81.
StahlSMBergerPA. Physostigmine in Tourette syndrome: Evidence for cholinergic underactivity. Am J Psychiatry1981; 138: 240–2
82.
SweetRDBruunRDShapiroAKShapiroES. The pharmacology of Gilles de la Tourette's syndrome (chronic multiple tic). In: KlawansH, ed. Clinica neuropharmacology, vol. 1. New York: Raven Press, 1976: 81–105
83.
GonceMBarbeauA. Seven cases of Gilles de la Tourette's syndrome: Partial relief with clonazepam: A pilot study. Can J Neurol Sci1977; 4: 279–83
84.
CohenDJDetlorJYoungJGShaywitzBA. Clonidine ameliorates Gilles de la Tourette syndrome. Arch Gen Psychiatry1980; 37: 1350–7
85.
CohenDJYoungLGNathansonAAShaywitzBA. Clonidine in Gilles de la Tourette's syndrome. Lancet1979; ii: 551–3
86.
SvenssonTHBunneyBSAghajanianGK. Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res. 1975; 92: 291–306